Letter

Global access to vaccines

Vaccine science and commerce: never the twain shall meet?

BMJ 2008; 336 doi: 10.1136/bmj.39563.553715.BE (Published 1 May 2008)
Cite this as: BMJ 2008;336:974.3

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Joseph L Mathew, assistant professor (paediatrics)
  1. 1Advanced Paediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India
  1. jlmathew{at}rediffmail.com

    Chokshi and Kesselheim suggest some reasons why effective vaccines are unavailable in poorer countries.1 The main reason is that most wealthy countries demand a solution (vaccine) for infectious diseases of public health importance, while poorer countries do not—and should they do so, they …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular